Lactulosum Polfarmex (Lactulose)

Lactulose reaches the colon unchanged, where bacterial enzymes split it into short‑chain acids. The resulting acidification increases the osmotic gradient, pulling water into the intestinal lumen, which softens stool and speeds transit. The acidic environment also converts ammonia (NH3) into ammonium (NH4+), reducing its absorption into the bloodstream and helping control hepatic encephalopathy.

The dose of Lactulosum Polfarmex is individualized by the prescribing clinician based on the patient’s condition, age, renal function, and response. The prescriber determines the appropriate amount and frequency, and patients should follow the specific instructions provided on the prescription label.

Lactulose is classified as a category C medication in many regions, meaning it should be used only if the potential benefit justifies the potential risk to the fetus. It is excreted in breast milk in small amounts; therefore, lactating mothers should consult their healthcare provider before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Lactulose is an osmotic laxative, differing from stimulant laxatives (e.g., bisacodyl) that increase intestinal motility. Compared with polyethylene glycol, lactulose also lowers ammonia levels, making it useful for hepatic encephalopathy. Its dual action—laxative effect and ammonia reduction—offers a therapeutic advantage in patients with liver disease.

Lactulosum Polfarmex should be stored below 25 °C in its original container, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to extreme temperatures, which could affect its stability and efficacy.

The medication is taken orally, usually as a liquid or powder that is dissolved in water or another suitable beverage. It should be consumed as directed by the prescriber, typically with or without food, and the full dose should be swallowed to ensure proper absorption and effect.

Serious risks include severe dehydration, electrolyte imbalances (especially low potassium), and rare cases of hyperosmolar coma. Patients should monitor for signs of excessive diarrhea, dizziness, or muscle weakness and seek medical attention promptly if these occur.

Individuals with known hypersensitivity to lactulose or its excipients should avoid the product. Patients with severe renal impairment, uncontrolled diabetes, or those who are pregnant without clear medical indication should use it only under close medical supervision.